Want to see JP:3671 full AI Analyst Report?
3671 Stock Chart & Stats
¥334.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥334.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥270.00 - ¥414.00
Previous CloseN/A
Volume5.20K
Average Volume (3M)30.83K
Market Cap
¥6.66B
Enterprise Value¥6.62B
Total Cash (Recent Filing)¥2.77B
Total Debt (Recent Filing)¥2.44B
Price to Earnings (P/E)12.9
Beta0.53
Next Earnings
Nov 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.61%
Share Statistics
EPS (TTM)21.54
Shares Outstanding24,050,800
10 Day Avg. Volume38,990
30 Day Avg. Volume30,833
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)2.04
Price to Sales (P/S)1.16
P/FCF Ratio20.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Durable ProfitabilityConsistent profitability across multiple years indicates that Softmax has maintained an economically viable healthcare IT operation despite recent weakness. Sustained net and EBIT margins provide an earnings base that can support product investment, customer service, and continued business operations.
Cash ConversionFree cash flow closely tracking net income suggests reported profits have generally converted into cash rather than depending heavily on non-cash accounting benefits. This supports internal funding capacity and gives the company greater flexibility to maintain systems and serve healthcare customers.
Healthcare IT Revenue ModelSoftmax operates in a specialized healthcare IT niche where deployments can generate both upfront implementation revenue and continuing maintenance or support fees. That model can deepen customer integration over time and create a durable base of post-deployment service activity.
Bears Say
Revenue ContractionThe sharp latest-year revenue decline signals weaker demand or deployment activity and interrupts the company’s preceding growth pattern. If the contraction persists, lower scale would reduce operating leverage, constrain reinvestment, and make recovery in earnings more dependent on renewed customer wins.
Margin CompressionA materially lower gross margin means less profit is retained from each unit of revenue, increasing the pressure on operating expenses and earnings quality. Continued compression could limit Softmax’s ability to absorb costs, fund development, and preserve its historically solid profitability.
Higher LeverageThe step-up in debt relative to equity reduces financial flexibility at a time when revenue and margins have weakened. Greater borrowing increases the importance of stable earnings and cash generation, while potentially limiting future investment or shareholder distributions if volatility continues.
3671 FAQ
What was Softmax Co., Ltd. (Japan)’s price range in the past 12 months?
Softmax Co., Ltd. (Japan) lowest stock price was ¥270.00 and its highest was ¥414.00 in the past 12 months.
What is Softmax Co., Ltd. (Japan)’s market cap?
Softmax Co., Ltd. (Japan)’s market cap is ¥6.66B.
When is Softmax Co., Ltd. (Japan)’s upcoming earnings report date?
Softmax Co., Ltd. (Japan)’s upcoming earnings report date is Nov 10, 2026 which is in 10 days.
How were Softmax Co., Ltd. (Japan)’s earnings last quarter?
Softmax Co., Ltd. (Japan) released its earnings results on Aug 12, 2026. The company reported ¥3.36 earnings per share for the quarter.
Is Softmax Co., Ltd. (Japan) overvalued?
According to Wall Street analysts Softmax Co., Ltd. (Japan)’s price is currently Overvalued.
Does Softmax Co., Ltd. (Japan) pay dividends?
Softmax Co., Ltd. (Japan) pays a Annually dividend of ¥10 which represents an annual dividend yield of 3.61%. See more information on Softmax Co., Ltd. (Japan) dividends here
What is Softmax Co., Ltd. (Japan)’s EPS estimate?
Softmax Co., Ltd. (Japan)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Softmax Co., Ltd. (Japan) have?
Softmax Co., Ltd. (Japan) has 24,050,800 shares outstanding.
What happened to Softmax Co., Ltd. (Japan)’s price movement after its last earnings report?
Softmax Co., Ltd. (Japan) reported an EPS of ¥3.36 in its last earnings report. Following the earnings report the stock price went up 1.948%.
Which hedge fund is a major shareholder of Softmax Co., Ltd. (Japan)?
Currently, no hedge funds are holding shares in JP:3671
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Softmax Co., Ltd. (Japan)
Softmax Co., Ltd handles the complete spectrum of corporate system services, encompassing their development, commercialization, deployment, and ongoing support. A significant portion of their work is dedicated to creating advanced medical information systems. Their offerings within the healthcare sector are diverse, comprising web-based electronic medical record (EMR) systems, online patient ordering platforms, medical financial management software, radiology information systems, and specialized solutions for rehabilitation departments, health screening, nursing task management, and surgical units. Established in 1974, Softmax Co., Ltd's corporate headquarters are located in Tokyo, Japan.